ID: ALA5273477

Max Phase: Preclinical

Molecular Formula: C21H15FN2O2

Molecular Weight: 346.36

Associated Items:

Representations

Canonical SMILES:  N#Cc1ccc(-c2ccc(CNc3cc(F)cc(C(=O)O)c3)cc2)cc1

Standard InChI:  InChI=1S/C21H15FN2O2/c22-19-9-18(21(25)26)10-20(11-19)24-13-15-3-7-17(8-4-15)16-5-1-14(12-23)2-6-16/h1-11,24H,13H2,(H,25,26)

Standard InChI Key:  GCGMDONLMUJQGT-UHFFFAOYSA-N

Associated Targets(Human)

Peroxisome proliferator-activated receptor alpha 9197 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 346.36Molecular Weight (Monoisotopic): 346.1118AlogP: 4.67#Rotatable Bonds: 5
Polar Surface Area: 73.12Molecular Species: ACIDHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.46CX Basic pKa: 2.63CX LogP: 4.31CX LogD: 1.62
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.70Np Likeness Score: -1.23

References

1. Lee JJ, Hu Z, Wang YA, Nath D, Liang W, Cui Y, Ma JX, Duerfeldt AS..  (2023)  Design, Synthesis, and Structure-Activity Relationships of Biaryl Anilines as Subtype-Selective PPAR-alpha Agonists.,  14  (6): [PMID:37312852] [10.1021/acsmedchemlett.3c00056]

Source